These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3138804)

  • 41. Effects of sub-lethal concentrations of mupirocin on global transcription in Staphylococcus aureus 8325-4 and a model for the escape from inhibition.
    AlHoufie STS; Foster HA
    J Med Microbiol; 2016 Aug; 65(8):858-866. PubMed ID: 27184545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of the growth promoting antibiotic mupirocin on the enterococci of fattening pigs.
    Kaukas A; Hinton M
    Br Vet J; 1988; 144(3):302-9. PubMed ID: 3135911
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fatty-acid composition of staphylococci induced by antibiotic AL-87 as a marker of their resistance or sensitivity to the given antibiotic].
    Smirnov VV; Churkina LN; Vasiurenko ZP; Kiprianova EA; Garagulia AD
    Antibiot Med Biotekhnol; 1985 Sep; 30(9):671-5. PubMed ID: 4062283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-antibiotic effect and killing activity of ciprofloxacin against Staphylococcus aureus.
    Fuursted K
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):199-202. PubMed ID: 3630713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth inhibition of Staphylococcus aureus by mixed monolayer gold nanoparticles.
    Bresee J; Maier KE; Boncella AE; Melander C; Feldheim DL
    Small; 2011 Jul; 7(14):2027-31. PubMed ID: 21630443
    [No Abstract]   [Full Text] [Related]  

  • 46. Elimination of Staphylococcus aureus carriage.
    Lund GC; Green DW; Ackerman NB
    Ann Intern Med; 1991 Jun; 114(11):990-1. PubMed ID: 1902637
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of antibiotic treatment on the intracellular nucleotide pools of Staphylococcus aureus.
    Greenwood RC; Gentry DR
    FEMS Microbiol Lett; 2002 Mar; 208(2):203-6. PubMed ID: 11959437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recovery period after exposure of Staphylococcus aureus to sub-inhibitory and bactericidal concentrations of rifampicin: clinical implications.
    Kitzis MD; Gutmann L; Acar JF
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():1-5. PubMed ID: 6469886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents.
    Stratton CW; Evans ME; Burch DJ; Hawley HB; Horsman TA; Tu KK; Reller LB
    Eur J Clin Microbiol; 1986 Jun; 5(3):351-3. PubMed ID: 3743559
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanism of bactericidal activity of lysolecithin and its biological implication.
    Kondo E; Kanai K
    Jpn J Med Sci Biol; 1985 Aug; 38(4):181-94. PubMed ID: 3938494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of the antibiotic AL-87 on the amino acid yield from Staphylococcus aureus 209P cells].
    Snirnov VV; Churkina LN; Kiprianova EA; Pustovalova LI
    Mikrobiol Zh (1978); 1991; 53(5):37-40. PubMed ID: 1791781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on a new antibiotic M-92 produced by Micromonospora. IV. Bactericidal action of the component VA-2.
    Tani K; Yamaguchi T
    J Antibiot (Tokyo); 1983 Mar; 36(3):289-95. PubMed ID: 6833149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Electron-radioautographic study of the action of "levosin" ointment and the ointment base (polyethylene oxide) on Staphylococcus aureus].
    Pal'tsyn AA; Blatun LA; Chervonskaia NV; Badikova AK
    Antibiot Khimioter; 1993; 38(4-5):14-8. PubMed ID: 8031189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic tolerance.
    Washington JA
    Ann Intern Med; 1981 Nov; 95(5):657-8. PubMed ID: 7294567
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of mupirocin on the growth and lifespan of human fibroblasts.
    Balin AK; Leong I; Carter DM
    J Invest Dermatol; 1987 Jun; 88(6):736-40. PubMed ID: 3108412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cultivation of Staphylococcus aureus in a synthetic medium of low ultraviolet absorptivity.
    Charles BG; Rawal BD
    Antimicrob Agents Chemother; 1976 Dec; 10(6):915-7. PubMed ID: 1008549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flow microcalorimetry as a tool for an improved analysis of antibiotic activity: the different stages of chloramphenicol action.
    Krüger D; Giesbrecht P
    Experientia; 1989 Apr; 45(4):322-5. PubMed ID: 2707369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic substance produced by a newly isolated marine microalga, Chlorococcum HS-101.
    Ohta S; Chang T; Ikegami N; Kondo M; Miyata H
    Bull Environ Contam Toxicol; 1993 Feb; 50(2):171-8. PubMed ID: 8422519
    [No Abstract]   [Full Text] [Related]  

  • 59. Distinct Effectiveness of Oritavancin against Tolerance-Induced
    Berti AD; Harven LT; Bingley V
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33171631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mupirocin in polyethylene glycol base is not suitable for application to burns.
    Kaczmarski EB
    J Antimicrob Chemother; 1988 Nov; 22(5):771. PubMed ID: 3145270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.